T2EVOLVE to be present at ASGCT’s Spotlight on IMMUNO-ONCOLOGY Conference

by Danny Liu | Jul 27, 2023 | Uncategorized

Project Coordinator Michael Hudecek will represent #T2EVOLVE alongside Maik Luu and Dirk Busch at ASGCT’s Spotlight on Immuno-Oncology Conference on August 1-2. The event features speakers and topics including novel CAR designs and approaches beyond B-Cell...

T2EVOLVE to be present at 2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients

by Danny Liu | Jul 3, 2023 | Uncategorized

T2EVOLVE partners Ulrich Jäger and Marie José Kersten will chair the European School of Haematology (ESH) meeting: 2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients. Abstract submission is open until 16 July. For more information about the...

T2EVOLVE meeting HNHCP at EHA2023

by Danny Liu | Jun 9, 2023 | Uncategorized

T2EVOLVE met with the Haematology Nurses and Healthcare Professionals Group on day 1 at the EHA2023 Congress in Frankfurt, Germany for an opportunity to share ideas and knowledge. We will be present at the Collaboration Plaza for the remainder of the congress, and...

Join T2EVOLVE at the EHA2023 Congress

by Danny Liu | May 25, 2023 | Uncategorized

T2EVOLVE will be present at EHA2023, the annual congress of the European Hematology Association. The hybrid congress runs from June 8 to June 15 with in-person sessions taking place in Frankfurt am Main in Germany.  T2EVOLVE Project Coordinator Michael Hudecek will be...

Thank you for joining us at the DG-GT workshop in Langen

by Danny Liu | May 3, 2023 | Uncategorized

T2EVOLVE thanks everyone for joining us at our roundtable discussion at the Deutsche Gesellschaft für Gentherapie e.V. (DG-GT) workshop, in Langen, Germany last week. The sessions discussing how we progress the parent-child IND concept from a regulatory point of view...